María Natalia Gandur Quiroga

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

María Natalia Gandur Quiroga
Sep 2, 2024, 08:35 | Insight
Shilpa Gupta: Novel approach of intermittent IO in mRCC
Shilpa Gupta shared a post on X by María Natalia Gandur Quiroga about a recent…
Aug 28, 2024, 18:15 | Insight
Understanding Gleason system evolution for accurate prostrate diagnosis and treatment, summary by María Natalia Gandur Quiroga
María Natalia Gandur Quiroga shared a recent article by Alessandro Crestani on X, adding: "Gleason…
Aug 27, 2024, 23:25 | Insight
Maria Natalia Gandur Quiroga: Key Findings from a Study on Intermediate-Risk Prostate Cancer
Maria Natalia Gandur Quiroga shared on X: “Key Findings from a Study on Intermediate-Risk Prostate…
Aug 14, 2024, 03:06 | Insight
Rethinking the role of lymph nodes in prostate cancer
Advanced Prostate Cancer Consensus Conference shared on X:  “From foes to friends: rethinking the role…
Aug 13, 2024, 07:06 | Blog
María Natalia Gandur Quiroga: Genetic testing in prostate cancer
María Natalia Gandur Quiroga shared a post by Advanced Prostate Cancer Consensus Conference, on X: "Genetic…
Aug 1, 2024, 04:07 | Blog
EORTC-1333-GUCG/PEACE III trial has reached it's primary endpoint
María Natalia Gandur Quiroga shared a post on X: "Exciting news from EORTC!  EORTC-1333-GUCG/PEACE III…
Jul 30, 2024, 12:17 | Blog
María Natalia Gandur Quiroga: Highlights from the article 'Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals'
María Natalia Gandur Quiroga posted on LinkedIn about recent paper by Irma Bisceglia et al., titled…
Jul 29, 2024, 23:27 | Insight
María Natalia Gandur Quiroga: Highlights from "The Rise of Supportive Oncology: A Revolution in Cancer Care"
María Natalia Gandur Quiroga shared a post on X about a recent paper titled "The…
Jul 26, 2024, 11:09 | Insight
Long-term Prostate Cancer Mortality Outcomes
María Natalia Gandur Quiroga shared on X about an article titled "Long-term Prostate Cancer–specific Mortality After…
Jul 25, 2024, 07:28 | Insight
María Natalia Gandur Quiroga: Study on Gleason Grade Group 1 Prostate Cancer reveals key findings
María Natalia Gandur Quiroga shared a post on X about a recent paper by Anthony…
Jul 22, 2024, 13:04 | Blog
Study on pRPLND in metastatic non-seminomatous germ cell tumors
María Natalia Gandur Quiroga posted on X about recent paper by Ahmad Mousa et al., commenting:…
Jul 22, 2024, 08:58 | Blog
Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing Data
Maria Natalia Gandur Quiroga shared on X: "Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic…
Jul 22, 2024, 08:16 | Blog
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation
Maria Natalia Gandur Quiroga shared on X: "Key Findings from the Study on Synergistic Effects of…
Jul 11, 2024, 06:37 | Insight
Results of the Complete Review on Targeted Therapies for Advanced Urothelial Carcinoma
María Natalia Gandur Quiroga shared on X: " Results and Main Messages of the Complete…
Jul 10, 2024, 11:57 | Blog
The 2024 Uromigos Cup
Uromigos formed in early 2017 as a group of friends attempting to provide balanced, scientific content…
Jun 29, 2024, 14:42 | Societies
María Natalia Gandur Quiroga: Key Takeaways from APCCC 2024
María Natalia Gandur Quiroga shared on X: "SUPER TALK! Main take home messages from APCC:…
Jun 25, 2024, 03:54 | Insight
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System
Maria Natalia Gandur Quiroga shared on LinkedIn: "Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring…
Jun 24, 2024, 12:08 | Blog
The prognostic value of PSA levels at 7-8 month
Yüksel Ürün shared a post on X:                 …
Jun 6, 2024, 13:18 | Blog
María Natalia Gandur Quiroga on JAVELIN Renal 101 trial by Camillo Porta
María Natalia Gandur Quiroga shared on X/Twitter: ''In It for the Long Run: Updated Outcomes…
May 23, 2024, 06:36 | Insight
María Natalia Gandur Quiroga: New insights on immunotherapy rechallenge in mRCC
María Natalia Gandur Quiroga shared on X: "New insights on immunotherapy rechallenge in mRCC! Key…
Apr 30, 2024, 11:54 | Societies
15 Posts Not To Miss from APCCC24!
The Advanced Prostate Cancer Consensus Conference 2024 (APCCC24) was held from April 25th to April…
Apr 15, 2024, 16:45 | Drugs
NCCN 2024 Prostate Cancer Guidelines Update by Maria Natalia Gandur Quiroga
Maria Natalia Gandur Quiroga shared a post on X: “NCCN 2024 Prostate Cancer Guidelines Update.…
Apr 11, 2024, 06:46 | Opinion
Maria Natalia Gandur Quiroga: The Hallmarks of Precancer
Maria Natalia Gandur Quiroga shared a post on X: "The Hallmarks of Precancer. AACR Journals,…
Apr 11, 2024, 06:39 | Insight
María Natalia Gandur Quiroga: Major updates from EAU24 on prostate cancer screening and diagnosis trials
María Natalia Gandur Quiroga shared on X/Twitter: "Major updates from EAU24 on prostate cancer (PCa) screening…
Mar 29, 2024, 19:30 | Insight
Maria Natalia Gandur Quiroga: New Insights on Bladder Cancer Invasion
Maria Natalia Gandur Quiroga shared on X/Twitter: "New Insights on Bladder Cancer Invasion. Unraveling a…
Mar 8, 2024, 14:46 | Blog
María Natalia Gandur Quiroga: Unveiling New Players in the Tumor Microenvironment: Tumor-Resident Microbes
María Natalia Gandur Quiroga shared a post on LinkedIn: “Unveiling New Players in the Tumor Microenvironment:…
Jan 31, 2024, 15:16 | Blog
María Natalia Gandur Quiroga: As always, Sumanta K. Pal's presentations are a masterclass
María Natalia Gandur Quiroga shared a post on X/Twitter: "Incredible insights from Sumanta K. Pal's…
Jan 26, 2024, 07:33 | Blog
María Natalia Gandur Quiroga: Fantastic article... One of the most anticipated!
María Natalia Gandur Quiroga posted on LinkedIn: "Fantastic article!  One of the most anticipated! New…
Jan 19, 2024, 08:43 | Drugs
María Natalia Gandur Quiroga: A significant advancement in bladder cancer treatment
María Natalia Gandur Quiroga shared on X/Twitter: "The article 'FGFR inhibition augments anti–PD-1 efficacy in…
Jan 18, 2024, 15:12 | Blog
Maria Natalia Gandur Quiroga: Immuno-Oncology Advances in Genitourinary Cancers
Maria Natalia Gandur Quiroga shared a post on LinkedIn: "Immuno-Oncology Advances in Genitourinary Cancers: Introduction:…
Dec 19, 2023, 16:41 | Insight
Maria Natalia Gandur Quiroga: Pioneering Equity in Cancer Treatment: A Model Worth Emulating
Maria Natalia Gandur Quiroga shared on LinkedIn: "Pioneering Equity in Cancer Treatment: A Model Worth…
Nov 27, 2023, 16:21 | Drugs
Maria Natalia Gandur Quiroga: Erdafitinib showcased its potential in a phase 3 trial
Maria Natalia Gandur Quiroga shared on LinkedIn: "Title: Advancements in Urothelial Carcinoma Treatment: Erdafitinib Outshines…
Nov 22, 2023, 03:04 | Drugs
Maria Natalia Gandur Quiroga: Promising results for zanzalintinib in advanced clear cell renal cell carcinoma treatment presented by Sumanta K. Pal
Quoting Maria Natalia Gandur Quiroga on X/Twitter: "Exciting updates from The Kidney Cancer Association's International…
Nov 12, 2023, 17:46 | Blog
María Natalia Gandur Quiroga: Very Proud of great professionals who accompany me every day
María Natalia Gandur Quiroga posted on X/Twitter. "Very Proud of great professionals who accompany me every…
Nov 4, 2023, 00:25 | Insight
María Natalia Gandur Quiroga: After a successful ESMO 23, ADC continues to shine
María Natalia Gandur Quiroga shared a post on X/Twitter: “After a successful ESMO 23, ADC…
Oct 23, 2023, 17:15 | Insight
María Natalia Gandur Quiroga: Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991 study results.
Quoting María Natalia Gandur Quiroga on X/Twitter: “Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991…
Oct 12, 2023, 18:13 | Blog
María Natalia Gandur Quiroga: Fantastic review! A pleasure to read: Understanding the Cancer-Immunity Cycle.
Quoting María Natalia Gandur Quiroga on X/Twitter: "Fantastic review! A pleasure to read: Understanding the Cancer-Immunity…
Sep 23, 2023, 18:52 | Blog
María Natalia Gandur Quiroga: Exciting advancements in Synthetic Biology for CAR T cell improvement!
Quoting María Natalia Gandur Quiroga, Chief of the Division of Genitourinary Medical Oncology at the…
Sep 23, 2023, 15:55 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 5
A month ago, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion…
All: 39 Posts: 1 - 100
Special Coverage